METTL3 and cervical cancer: Taken together, cervical cancer progression involved a high METTL3 expression, and the elevated METTL3 expression reduced DLG2 release in an m6A-dependent manner to activate the Hippo/YAP pathway, further promoting tumor cell proliferation, migration and invasion and inhibiting cell apoptosis.